Tianhong Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tianhong Zhang has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
Mengting Liu
7 shared publicationsTianyu Ma
Department of Otorhinolaryngology Head and Neck Surgery The First Hospital Affiliated to Harbin Medical University Harbin Heilongjiang China
6 shared publicationsChenyang Yuan
3 shared publicationsGongrui Tang
Department of Otorhinolaryngology Head and Neck Surgery The First Hospital Affiliated to Harbin Medical University Harbin Heilongjiang China
3 shared publicationsQi Hu
3 shared publicationsYuyao Wang
The First Affiliated Hospital of Harbin Medical University, Harbin, China
3 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (11)
Schisantherin B Preserves Cochlear Function and Hair Cell Integrity in Aging by Restoring Mitochondrial Homeostasis via eEF1A2 –Beclin‐1–Mediated Mitophagy
Background: Age‐related hearing loss (ARHL) represents one of the prevalent degenerative conditions in the elderly worldwide, characterized by progressive auditory dysfunction that impairs quality of life. Currently, no approved pharmacotherapies are available to prevent. Methods: In vitro protective effects of STB were assessed by cell viability and Senescence‐associated β‐galactosidase (SA‐β‐gal staining) in D‐galactose‐induced senescent mouse cochlear explants and HEI‐OC1 cells. In vivo auditory function and cochlear injury were examined by hearing threshold detection and histological analysis of hair cells, ribbon synapses, and spiral ganglion neurons in SAMP8 and C57BL/6J mice. RNA sequencing was used to identify STB‐mediated transcriptional changes. Immunofluorescence and Western blotting were performed to investigate the molecular mechanisms. Results: STB pretreatment reduced cell loss and senescence in vitro. In vivo, STB attenuated low‐to‐mid frequency hearing threshold shifts and cochlear degeneration. Mechanistically, STB upregulated eEF1A2, which promoted Beclin‐1‐mediated mitophagy, reduced ROS accumulation, and suppressed caspase‐3‐dependent apoptosis. RNA‐seq confirmed that STB modulated Beclin‐1 expression via eEF1A2. Conclusion: These data confirm the significant protective effect of STB against ARHL, highlighting its potential as a natural candidate for ARHL intervention and verify that it exerts its effects by regulating cellular autophagy via the eEF1A2‐Beclin 1 pathway.
- 13 November 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (11)
Open AccessSchisantherin B Preserves Cochlear Function and Hair Cell Integrity in Aging by Restoring Mitochondrial Homeostasis via eEF1A2 –Beclin‐1–Mediated Mitophagy
Background: Age‐related hearing loss (ARHL) represents one of the prevalent degenerative conditions in the elderly worldwide, characterized by progressive auditory dysfunction that impairs quality of life. Currently, no approved pharmacotherapies are available to prevent. Methods: In vitro protective effects of STB were assessed by cell viability and Senescence‐associated β‐galactosidase (SA‐β‐gal staining) in D‐galactose‐induced senescent mouse cochlear explants and HEI‐OC1 cells. In vivo auditory function and cochlear injury were examined by hearing threshold detection and histological analysis of hair cells, ribbon synapses, and spiral ganglion neurons in SAMP8 and C57BL/6J mice. RNA sequencing was used to identify STB‐mediated transcriptional changes. Immunofluorescence and Western blotting were performed to investigate the molecular mechanisms. Results: STB pretreatment reduced cell loss and senescence in vitro. In vivo, STB attenuated low‐to‐mid frequency hearing threshold shifts and cochlear degeneration. Mechanistically, STB upregulated eEF1A2, which promoted Beclin‐1‐mediated mitophagy, reduced ROS accumulation, and suppressed caspase‐3‐dependent apoptosis. RNA‐seq confirmed that STB modulated Beclin‐1 expression via eEF1A2. Conclusion: These data confirm the significant protective effect of STB against ARHL, highlighting its potential as a natural candidate for ARHL intervention and verify that it exerts its effects by regulating cellular autophagy via the eEF1A2‐Beclin 1 pathway.
- Open Access
Molecular taxonomy and spatial organization define neuronal subtypes in the mouse inferior colliculus
- 25 February 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 248, 450-468
NRH attenuates age-related hearing loss by suppressing cochlear ferroptosis and cellular senescence via Sirt3 activation
- 25 February 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 248, 450-468
NRH attenuates age-related hearing loss by suppressing cochlear ferroptosis and cellular senescence via Sirt3 activation
- Open Access
- 28 January 2026
- Published by Elsevier in Biochemical Pharmacology
- Vol. 247, 117759
Obacunone mitigates cisplatin-induced ototoxicity by activating CRHBP-mediated autophagy
- 28 January 2026
- Published by Elsevier in Biochemical Pharmacology
- Vol. 247, 117759
Open AccessObacunone mitigates cisplatin-induced ototoxicity by activating CRHBP-mediated autophagy
- 26 November 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (46) , 15038-15046
Corneal retention using a nanorobot-based eyedrop
We present a nanorobot-based eyedrop that offers active retention on the corneal surface. This active delivery platform significantly enhances the antifungal efficacy against fungal keratitis.
- 26 November 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (46) , 15038-15046
Corneal retention using a nanorobot-based eyedrop
We present a nanorobot-based eyedrop that offers active retention on the corneal surface. This active delivery platform significantly enhances the antifungal efficacy against fungal keratitis.
- Open Access
- 3 November 2025
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 8 (11) , 10419-10435
Mesoporous Silica Nanoparticles for Quercetin-Controlled Delivery to Protect Cisplatin-Induced Ototoxicity
Cisplatin (CDDP), a widely used chemotherapeutic agent, is limited by severe ototoxicity side effects. Local drug delivery via the middle ear represents the most effective approach for treating inner ear disease. However, therapeutic efficacy is constrained by poor middle ear retention and limited permeability across the round window membrane (RWM). Quercetin (QU) exhibits potent activity against CDDP-induced cytotoxicity but suffers from delivery challenges. To address this, we developed amino-functionalized mesoporous silica nanoparticles (NH2-MSNs) loaded with QU (QU-N-MSNs), leveraging the permselective properties of the RWM. This system was noninvasively administered to the cochlea via trans-tympanic delivery. The synthesized QU-N-MSNs demonstrated a uniform particle size of approximately 116-124 nm, positive charge, and sustained drug release properties. Compared to free QU, QU-N-MSNs demonstrated significantly enhanced antiapoptotic and cytoprotective activities in vitro. In vivo studies confirmed nanoparticle retention within the inner ear for ≥14 days post administration and efficient RWM penetration. Pretreatment with QU-N-MSNs prior to CDDP exposure in murine models substantially mitigated ototoxicity, as evidenced by reduced hearing threshold shifts across multiple frequencies, preservation of hair cells (HCs) and spiral ganglion neurons (SGNs), and attenuation of mitochondrial-mediated SGN apoptosis. These findings establish QU-N-MSNs as an effective RWM-penetrating delivery platform, offering a promising strategy to enhance hydrophobic drug bioavailability in the inner ear and prevent CDDP-induced ototoxicity.
- 3 November 2025
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 8 (11) , 10419-10435
Open AccessMesoporous Silica Nanoparticles for Quercetin-Controlled Delivery to Protect Cisplatin-Induced Ototoxicity
Cisplatin (CDDP), a widely used chemotherapeutic agent, is limited by severe ototoxicity side effects. Local drug delivery via the middle ear represents the most effective approach for treating inner ear disease. However, therapeutic efficacy is constrained by poor middle ear retention and limited permeability across the round window membrane (RWM). Quercetin (QU) exhibits potent activity against CDDP-induced cytotoxicity but suffers from delivery challenges. To address this, we developed amino-functionalized mesoporous silica nanoparticles (NH2-MSNs) loaded with QU (QU-N-MSNs), leveraging the permselective properties of the RWM. This system was noninvasively administered to the cochlea via trans-tympanic delivery. The synthesized QU-N-MSNs demonstrated a uniform particle size of approximately 116-124 nm, positive charge, and sustained drug release properties. Compared to free QU, QU-N-MSNs demonstrated significantly enhanced antiapoptotic and cytoprotective activities in vitro. In vivo studies confirmed nanoparticle retention within the inner ear for ≥14 days post administration and efficient RWM penetration. Pretreatment with QU-N-MSNs prior to CDDP exposure in murine models substantially mitigated ototoxicity, as evidenced by reduced hearing threshold shifts across multiple frequencies, preservation of hair cells (HCs) and spiral ganglion neurons (SGNs), and attenuation of mitochondrial-mediated SGN apoptosis. These findings establish QU-N-MSNs as an effective RWM-penetrating delivery platform, offering a promising strategy to enhance hydrophobic drug bioavailability in the inner ear and prevent CDDP-induced ototoxicity.
- Open Access
- 25 April 2025
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 17, 1526519
Experimental validation and identification of ferroptosis-associated biomarkers for diagnostic and therapeutic targeting in hearing loss
Objectives: Ferroptosis, a regulated form of cell death, has attracted significant attention in hearing loss research; however, the role of ferroptosis-related genes remains unclear. This study aimed to clarify diagnostic and therapeutic targeting of ferroptosis-related genes in hearing loss.Methods: Differentially expressed genes related to hearing loss from the GEO database were intersected with ferroptosis-related genes. The Lasso and SVM-RFE models were applied to reduce the gene set, identifying model genes. Biological functions, pathways, and gene-drug associations related to these model genes were analyzed. Age-related hearing loss (ARHL) genes within the model genes were obtained from a genome-wide association study (GWAS) dataset. Further validation was conducted in HEI-OC1 cells and the cochleae of C57BL/6J mice, including auditory brainstem response (ABR) testing, qRT-PCR, Western blotting, Fe2+ detection, and immunofluorescence analysis.Results: The study identified 20 ferroptosis-related genes associated with hearing loss. Using Lasso and SVM-RFE models, a novel model was constructed, consisting of nine genes (SCD, ENPP2, PANX2, NEDD4, MEF2C, ABCC5, KLHDC3, CYP4F8 and IFNA2). Among these, MEF2C and NEDD4 were found to be associated with ARHL.Conclusion: Ferroptosis is a potential pathological mechanism in hearing loss research, and the nine ferroptosis-related genes identified provide promising targets for exploring new diagnostics and treatments for hearing loss. Notably, MEF2C and NEDD4 are associated with ARHL.
- 25 April 2025
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 17, 1526519
Open AccessExperimental validation and identification of ferroptosis-associated biomarkers for diagnostic and therapeutic targeting in hearing loss
Objectives: Ferroptosis, a regulated form of cell death, has attracted significant attention in hearing loss research; however, the role of ferroptosis-related genes remains unclear. This study aimed to clarify diagnostic and therapeutic targeting of ferroptosis-related genes in hearing loss.Methods: Differentially expressed genes related to hearing loss from the GEO database were intersected with ferroptosis-related genes. The Lasso and SVM-RFE models were applied to reduce the gene set, identifying model genes. Biological functions, pathways, and gene-drug associations related to these model genes were analyzed. Age-related hearing loss (ARHL) genes within the model genes were obtained from a genome-wide association study (GWAS) dataset. Further validation was conducted in HEI-OC1 cells and the cochleae of C57BL/6J mice, including auditory brainstem response (ABR) testing, qRT-PCR, Western blotting, Fe2+ detection, and immunofluorescence analysis.Results: The study identified 20 ferroptosis-related genes associated with hearing loss. Using Lasso and SVM-RFE models, a novel model was constructed, consisting of nine genes (SCD, ENPP2, PANX2, NEDD4, MEF2C, ABCC5, KLHDC3, CYP4F8 and IFNA2). Among these, MEF2C and NEDD4 were found to be associated with ARHL.Conclusion: Ferroptosis is a potential pathological mechanism in hearing loss research, and the nine ferroptosis-related genes identified provide promising targets for exploring new diagnostics and treatments for hearing loss. Notably, MEF2C and NEDD4 are associated with ARHL.
- Open Access
- 23 April 2025
- Published by Elsevier in Ultrasonics Sonochemistry
- Vol. 118, 107368
Ultrasound-responsive nanobubble-mediated sonodynamic therapy sensitizes disulfidptosis in the treatment of liver hepatocellular carcinoma
- 23 April 2025
- Published by Elsevier in Ultrasonics Sonochemistry
- Vol. 118, 107368
Open AccessUltrasound-responsive nanobubble-mediated sonodynamic therapy sensitizes disulfidptosis in the treatment of liver hepatocellular carcinoma
- Open Access
- 5 March 2025
- Published by Springer Nature in BMC Genomics
- Vol. 26 (1) , 1-11
Analysis and identification of mitochondria-related genes associated with age-related hearing loss
To explore the mitochondrial genes that play a key role in the occurrence and development of age-related hearing loss (ARHL) and provide a basis for the study of the mechanism of ARHL. 503 differentially expressed genes (DEGs) were detected in the GSE49543 dataset. 233 genes were up-regulated, and 270 genes were down-regulated. There are 1140 genes in the mitochondrial gene bank, and 28 differentially expressed genes related to ARHL. These genes are mainly involved in mitochondrial respiratory chain complex assembly, small molecule catabolism, NADH dehydrogenase complex assembly, organic acid catabolism, precursor metabolites and energy production, and mitochondrial span Membrane transport, metabolic processes of active oxygen species. Then, Cytoscape software identified the three key genes: Aco2, Bcs1l and Ndufs1. Immunofluorescence and Western blot experiments confirmed that the protein content of three key genes in aging cochlear hair cells decreased. We employed bioinformatics analysis to screen 503 differentially expressed genes and identified three key genes associated with ARHL. Subsequently, we conducted in vitro experiments to validate their significance, thereby providing a valuable reference for further elucidating the role of mitochondrial function in the pathogenesis and progression of ARHL.
- 5 March 2025
- Published by Springer Nature in BMC Genomics
- Vol. 26 (1) , 1-11
Open AccessAnalysis and identification of mitochondria-related genes associated with age-related hearing loss
To explore the mitochondrial genes that play a key role in the occurrence and development of age-related hearing loss (ARHL) and provide a basis for the study of the mechanism of ARHL. 503 differentially expressed genes (DEGs) were detected in the GSE49543 dataset. 233 genes were up-regulated, and 270 genes were down-regulated. There are 1140 genes in the mitochondrial gene bank, and 28 differentially expressed genes related to ARHL. These genes are mainly involved in mitochondrial respiratory chain complex assembly, small molecule catabolism, NADH dehydrogenase complex assembly, organic acid catabolism, precursor metabolites and energy production, and mitochondrial span Membrane transport, metabolic processes of active oxygen species. Then, Cytoscape software identified the three key genes: Aco2, Bcs1l and Ndufs1. Immunofluorescence and Western blot experiments confirmed that the protein content of three key genes in aging cochlear hair cells decreased. We employed bioinformatics analysis to screen 503 differentially expressed genes and identified three key genes associated with ARHL. Subsequently, we conducted in vitro experiments to validate their significance, thereby providing a valuable reference for further elucidating the role of mitochondrial function in the pathogenesis and progression of ARHL.
- Open Access
- 3 July 2024
- Published by Elsevier in Experimental Gerontology
- Vol. 194, 112489
Research trends and hotspot analysis of age-related hearing loss: A bibliometric analysis from 2019 to 2023
- 3 July 2024
- Published by Elsevier in Experimental Gerontology
- Vol. 194, 112489
Open AccessResearch trends and hotspot analysis of age-related hearing loss: A bibliometric analysis from 2019 to 2023